PMID- 33212866 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201201 IS - 1424-8247 (Print) IS - 1424-8247 (Electronic) IS - 1424-8247 (Linking) VI - 13 IP - 11 DP - 2020 Nov 17 TI - Using Carbomer-Based Hydrogels for Control the Release Rate of Diclofenac Sodium: Preparation and In Vitro Evaluation. LID - 10.3390/ph13110399 [doi] LID - 399 AB - The aim of the current research work was to prepare Car934-g-poly(acrylic acid) hydrogels by the free-radical polymerization technique. Various concentrations of carbopol, acrylic acid and ethylene glycol dimethacrylate were employed for the fabrication of Car934-g-poly(acrylic acid) hydrogels. Fourier-transform infrared spectroscopy (FTIR), Thermogravimetric analysis (TGA), Differential scanning calorimetry (DSC), Scanning electron microscope (SEM) and Powder X-ray diffractometry (PXRD) studies were performed to know the structural arrangement, thermal stability, physical appearance and amorphous network of developed hydrogels. FTIR analysis revealed that carbopol reacted with acrylic acid during the process of polymerization and confirmed the grafting of acrylic acid over the backbone of carbopol. TGA and DSC studies showed that developed hydrogels were thermally stable. Surface morphology was analyzed by SEM, which confirmed a porous network of hydrogels. PXRD analysis indicated that crystallinity of the drug was reduced by the amorphous network of hydrogels. Furthermore, swelling studies for all developed hydrogels were performed at both media, i.e., pH 1.2 and 7.4, and higher swelling was exhibited at pH 7.4. Sol-gel analysis was performed to evaluate the soluble unreacted part of the fabricated hydrogels. Similarly, an in-vitro study was conducted for all hydrogel formulations at both acidic (pH 1.2) and basic (pH 7.4) mediums, and a greater drug release was observed at pH 7.4. Different kinetics such as zero-order, first-order, the Higuchi model and the Korsmeyer-Peppas model were applied to know the mechanism of release order of drugs from the hydrogels. FAU - Suhail, Muhammad AU - Suhail M AD - School of Pharmacy, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung City 80708, Taiwan. FAU - Wu, Pao-Chu AU - Wu PC AUID- ORCID: 0000-0001-8852-0534 AD - School of Pharmacy, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung City 80708, Taiwan. AD - Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. AD - Drug development and value creation research center, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. FAU - Minhas, Muhammad Usman AU - Minhas MU AUID- ORCID: 0000-0001-7313-8500 AD - College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan. LA - eng GR - MOST 109-2320-B-037-0025/National Science Council/ PT - Journal Article DEP - 20201117 PL - Switzerland TA - Pharmaceuticals (Basel) JT - Pharmaceuticals (Basel, Switzerland) JID - 101238453 PMC - PMC7698439 OTO - NOTNLM OT - carbopol OT - diclofenac sodium OT - hydrogels OT - in-vitro study COIS- The authors declare no conflict of interest. EDAT- 2020/11/21 06:00 MHDA- 2020/11/21 06:01 PMCR- 2020/11/01 CRDT- 2020/11/20 01:01 PHST- 2020/10/09 00:00 [received] PHST- 2020/11/13 00:00 [revised] PHST- 2020/11/14 00:00 [accepted] PHST- 2020/11/20 01:01 [entrez] PHST- 2020/11/21 06:00 [pubmed] PHST- 2020/11/21 06:01 [medline] PHST- 2020/11/01 00:00 [pmc-release] AID - ph13110399 [pii] AID - pharmaceuticals-13-00399 [pii] AID - 10.3390/ph13110399 [doi] PST - epublish SO - Pharmaceuticals (Basel). 2020 Nov 17;13(11):399. doi: 10.3390/ph13110399.